₅Ioannis E Koutroubakis

Summary for 2004 [at-glance overview of Ioannis E Koutroubakis work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author Ioannis E Koutroubakis. According to available data, in 2004 Ioannis E Koutroubakis published at least 5 articles. This work was completed in collaboration with several authors including Kouroumalis, Elias A and Sfiridaki, Aekaterini. Several other authors have collaborated with Ioannis E Koutroubakis as well. There is no information about the funding or the grants awarded to support this work.

Ioannis E Koutroubakis has rank 49 when compared to all other authors using the keyword Crohn Disease. Analysis of the article abstracts and the titles suggests that Ioannis E Koutroubakis professional interests are focused around "inflammatory bowel disease", "angiogenin inflammatory bowel" and "hypercoagulable states patients". These might also be referred to as "inflammatory bowel", "bowel disease" or "serum angiogenin". Statistical analysis shows that Ioannis E Koutroubakis's writing is likely to contains terms "patients", "disease", "angiogenin", "levels", "serum" and "significantly".

Unfortunately, there is not enough information to establish Ioannis E Koutroubakis affiliation. Luckily, one email address is on file.

EN FR ES RU

Inaccurate information, needs improvement

make correction leave comment ask question

Images [images we found on the Internet for Ioannis E Koutroubakis]

Do you know Ioannis E Koutroubakis who matches the profile above? Click the photo and let us know!

Alternative names (1) [other authors with names similar to Ioannis E Koutroubakis]

₂₀Koutroubakis, I E

Year 2004 Charts [Ioannis E Koutroubakis frequent coauthors and the most common unique vocabulary terms for the selected year]

Historical Performance Charts [graphical overview of Ioannis E Koutroubakis publication and funding history for the range of years]

Emails (1) [email addresses extracted from Ioannis E Koutroubakis affiliations]

hidden to prevent spam, click here to reveal

Ioannis E Koutroubakis Coauthors (10) [all coauthors with the number of joint publications]

explore visually

5

₉Kouroumalis, Elias A

3

₃Sfiridaki, Aekaterini

2

₆Xidakis, Costas

2

₅Malliaraki, Niki

2

₂Karmiris, Konstantinos

2

₂Theodoropoulou, Angeliki

1

1

1

1

Other [context-specific ads]

Affiliations (3) [condensed summary of the Ioannis E Koutroubakis affiliations, the leading number and the color conveys importance]

₂Department of Gastroenterology, University Hospital Heraklion, Heraklion, Crete, Greece.
₁Department of Gastroenterology University Hospital Heraklion; and Regional Blood Bank Center Venizelion Hospital Heraklion, Crete, Greece.
₁Department of Gastroenterology, University Hospital Heraklion, P.O. Box 1352, Heraklion 71110, Greece.

Key Opinion Leader In [Ioannis E Koutroubakis is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

₄₉Crohn Disease | ₇₃Colitis, Ulcerative | ₄₆₃Biological Markers

Keywords (32) [keywords assigned to Ioannis E Koutroubakis articles by PubMed, the leading number and the color conveys importance]

₅Humans | ₅Adult | ₅Female | ₄Crohn Disease | ₄Male | ₃Middle Aged | ₃Biological Markers | ₃Colitis, Ulcerative | ₂Inflammatory Bowel Diseases | ₂Aged | ₁Protein S | ₁Peptide Hydrolases | ₁Peptide Fragments | ₁Thromboembolism | ₁Lipoprotein(a) | ₁Sensitivity and Specificity | ₁Ribonuclease, Pancreatic | ₁Severity of Illness Index | ₁Protein C | ₁Oxidative Stress | ₁Antithrombin III | ₁Antithrombins | ₁Gastrointestinal Agents | ₁Solubility | ₁Cohort Studies | ₁Carcinoma, Hepatocellular | ₁Esophagitis | ₁Antioxidants | ₁Platelet Count | ₁CD40 Ligand | ₁Probability | ₁Antibodies, Monoclonal

Ioannis E Koutroubakis Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Ioannis E Koutroubakis might be a good expert witness on these terms]

₂₉patients | ₂₂disease | ₁₂angiogenin | ₁₂levels | ₁₀serum | ₉significantly | ₈compared | ₈bowel | ₈inflammatory | ₇controls | ₇hcc | ₆mean | ₆cd | ₆uc | ₆ibd | ₅healthy | ₄association | ₄scd40l | ₄ctac | ₄tac | ₄higher | ₄activity | ₄different | ₃plasma | ₃increased | ₃lower | ₃found | ₃colitis | ₃inactive | ₃state | ₃active | ₃localization
₈inflammatory bowel | ₈bowel disease | ₆serum angiogenin | ₅healthy controls | ₄hcc patients | ₄disease activity | ₃significantly lower | ₃significantly higher | ₃patients active | ₃patients hcc | ₃angiogenin levels | ₃ibd patients | ₃cd patients | ₃inactive disease | ₃tac ctac | ₃hepatocellular carcinoma | ₂vascular permeability | ₂serum levels | ₂soluble cd40 | ₂states patients | ₂compared inactive | ₂matched healthy | ₂crohn disease | ₂mean serum | ₂patients hepatocellular | ₂angiogenin inflammatory | ₂compared controls | ₂prothrombotic state | ₂patients ibd | ₂lower mean | ₂association enhanced | ₂enhanced soluble
₈inflammatory bowel disease | ₂angiogenin inflammatory bowel | ₂hypercoagulable states patients | ₂significantly lower mean | ₂ligand prothrombotic state | ₂cd40 ligand prothrombotic | ₂compared inactive disease | ₂soluble cd40 ligand | ₂enhanced soluble cd40 | ₂association enhanced soluble | ₂prothrombotic state inflammatory | ₂serum angiogenin inflammatory | ₂states patients hepatocellular | ₂matched healthy controls | ₂patients hepatocellular carcinoma | ₂tac ctac compared | ₂state inflammatory bowel | ₂antioxidant capacity patients | ₂decreased total corrected | ₂corrected antioxidant capacity | ₂capacity patients inflammatory | ₂patients ng ml | ₂patients inflammatory bowel | ₂total corrected antioxidant | ₁cirrhosis without hcc | ₁tissue repair activating | ₁angiogenesis vascular permeability | ₁ibd serum angiogenin | ₁inflammation matched healthy | ₁uc different tac | ₁hepatocellular carcinoma serum | ₁higher scd40l levels

Reader's Comments (0) [comments posted by readers of Ioannis E Koutroubakis profile]